NKX2-1 and cystic fibrosis: The advantages of hiLOs derived from NKX2.1+ lung progenitors and hiBCs are an almost limitless supply of patient-specific cells, direct connection of the respiratory tract with the cystic fibrosis pathology and thus greater relevance with respect to CF modeling.